1. Hahne SJ, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, Van Binnendijk RS (2016) Measles outbreak among previously immunized healthcare workers, The Netherlands, 2014. J Infect Dis 214(12):1980–1986. https://doi.org/10.1093/infdis/jiw480
2. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease C, Prevention (2013) Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62(RR-04):1–34
3. Bolotin S, Hughes SL, Gul N, Khan S, Rota PA, Severini A, Hahne S, Tricco A, Moss WJ, Orenstein W, Turner N, Durrheim D, Heffernan JM, Crowcroft N (2020) What is the evidence to support a correlate of protection for measles? A systematic review. J Infect Dis 221(10):1576–1583. https://doi.org/10.1093/infdis/jiz380
4. Lutz CS, Hasan AZ, Bolotin S, Crowcroft NS, Cutts FT, Joh E, Loisate S, Moss WJ, Osman S, Hayford K (2023) Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT. BMC Infect Dis 23(1):367. https://doi.org/10.1186/s12879-023-08199-8
5. Cohen BJ, Audet S, Andrews N, Beeler J, test WHOwgomprn (2007) Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26 (1):59–66. doi:https://doi.org/10.1016/j.vaccine.2007.10.046